University of Miami
Miami, Florida, 33136, United States
NCT Number: NCT06159361
The purpose of this study is to examine the effects of a postural adjustment, targeted training program on balance ability and postural responses anticipatory postural adjustments (APA) and compensatory postural adjustments (CPA) in individuals with MS
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Miami, Florida, 33136, United States
All participants participated in individual training program aimed at improving balance ability and postural adjustments. The training program and individual activities were based on previously published programs and motor learning principles, and consists of 18, 1-hour training sessions over six weeks (3 sessions/week). Training occurred in person 2 days a week (in person training) and at home (home exercise program) 1 day a week, for a total of 3 sessions per week. The duration of training sessions were 60 minutes per session for a total of 1,140 minutes of training. The exercise room temperature was centrally regulated (23.3 degrees C).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6-week exercise program, 3 sessions per week (2 sessions in person, 1 session of home exercises. Participants will receive a booklet with information about the home exercises and will receive a text message reminder), each session will last 60 minutes.
Time frame: Baseline, 6 weeks (post intervention)
The Balance Evaluation Systems Test (BESTest) will be used to measure balance ability. Items are scored from 0 (severe impairment) to 3 (no impairment), with a total score of 108. A higher score suggests better balance ability.
Time frame: Baseline, 6 weeks (post intervention)
Measure in seconds
Time frame: Baseline, 6 weeks (post intervention)
Measure in degree per second
Time frame: Baseline, 6 weeks (post intervention)
measure of endpoint excursion in a percentage out of a100
Time frame: Baseline, 6 weeks (post intervention)
measure of directional control in a percentage out of a100
Time frame: Baseline, 6 weeks (post intervention)
measure of maximum excursion in a percentage out of a100
Time frame: Baseline, 6 weeks (post intervention)
The Motor Control test (MCT) measures the subject's ability to generate a motor response latency to a sudden surface translation in a forward and backward direction at three different magnitudes (small, medium, and large).
Latency: The time-lapse between the perturbation onset and the subject response for each limb. The latency is reported in milliseconds.
Time frame: Baseline, 6 weeks (post intervention)
Postural muscles responses onset latency in seconds
Time frame: Baseline, 6 weeks (post intervention)
Postural muscles APA measured in microvolts
Time frame: Baseline, 6 weeks (post intervention)
Postural muscles CPA in microvolts
Time frame: Baseline, 6 weeks (post intervention)
The Activities Specific Balance Confidence (ABC) scale is a self-report questionnaire of a subject's perceived level of balance confidence. It measures the subject's confidence in performing various ambulatory activities without falling. There are 16 items scored using a scale(0-100) with higher scores indicating more confidence in performing the tasks. A total score is reported by dividing the total ABC score by 16.
Time frame: Baseline, 6 weeks (post intervention)
Multiple Sclerosis Quality of Life - 54 (MSQoL-54) is a self-report questionnaire measuring subject perceived of quality of life. In total, it contains 54 items with a total score ranging from 0-100, with higher scores indicating a better quality of life
University of Miami
Other
The Effect of a Targeted Exercise Program on Balance and Postural Responses in Patients With Multiple Sclerosis (MS)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03963375
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
St Louis, Missouri, United States
View Trial DetailsNCT02511028
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bethesda, Maryland, United States
View Trial DetailsNCT07175792
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Diepenbeek, Belgium
View Trial DetailsNCT07726667
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Gaziantep, Gaz, Turkey (Türkiye)
View Trial Details